VistaPharm Recalls
36 recalls on record · July 18, 2012 to December 6, 2023 · Drugs
Recalls by year
12
13
14
15
16
17
18
20
22
23
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
December 18, 2013DrugsFDA
VistaPharm, Inc. recalls Phenytoin Oral Suspension USP 125mg/5mL, 50 cups per case, For Oral Administration Only, Rx Only, Manufactured by: Vist
Hazard: Defective Container: A lidding deformity allowed for the product to have out of specification results for assay and viscosity at the12 month stability timepoint.
August 28, 2013DrugsFDA
VistaPharm, Inc. recalls Nystatin Oral Suspension, USP 500,000 units/ 5 mL (NDC 66689-037-01 ) Rx Only, Manufactured by VistaPharm, Inc. Largo,
Hazard: Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.
September 5, 2012DrugsFDA
VistaPharm, Inc. recalls METOCLOPRAMIDE ORAL SOLUTION, USP 5 mg/5 mL, This cup delivers 10 mL, Rx Only, Manufactured by VistaPharm, Inc., Largo F
Hazard: Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed "5 mL x 50," instead of "10 mL x 50,"
August 29, 2012DrugsFDA
VistaPharm, Inc. recalls Xactdose Phenytoin Oral Suspension, USP, 125mg/ 5 mL, supplied in 5 mL unit dose cups, Manufactured by VistaPharm, Inc.,
Hazard: Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume
August 8, 2012DrugsFDA
VistaPharm, Inc. recalls Xactdose Phenytoin Oral Suspension, USP 125 mg/5mL, supplied in 5 mL unit dose cups, VISTAPHARM, Largo, FL NDC 66689-03
Hazard: Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume.
July 18, 2012DrugsFDA
VistaPharm, Inc. recalls Hydrocodone Bitartrate & Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL, a) 15 mL Unit Dose Cups (50 unit dose cups
Hazard: Impurities/Degradation Products: exceeded specification at 3 month stability testing